© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 5, 333,
March 7, 2001
© 2001 Oxford University Press
IN THIS ISSUE |
Women and their clinicians are encouraged to use risk estimates derived from statistical models, primarily the model of Gail et al., to aid decision making regarding potential prevention options for breast cancer, including chemoprevention with tamoxifen. Rockhill et al. (p. 358) used women in the Nurses Health Study to evaluate the Gail et al. model 2, which predicts the risk of developing invasive breast cancer. They looked at two statistical conceptsgoodness of fit and discriminatory accuracy at the individual level. They concluded that the model
Genetic Variability in Human T-Cell Leukemia Virus Type 1
Environmental Tobacco Smoke Carcinogens in Nonsmokers
Antiangiogenic Therapy and Tumor Growth
Prostate Cancer and Ethnicity